arrow
P

Pedro Farinha

bc cancer centre for lymphoid cancer
H指数:50
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

LySeqST: A targeted sequencing assay for robust genomic classification of diffuse large B-cell lymphoma

LySeqST:一种用于弥漫性大B细胞淋巴瘤稳健基因组分类的靶向测序检测方法

2026-04-170
OAAI
Gene expression profiling reveals two overarching types of ALCL with distinct targetable biology: an LLMPP study

基因表达谱分析揭示了两种主要的ALCL类型,具有不同的可靶向生物学特征:LLMPP研究

Blood
IF23.1
2025-11-240
PRE
Population-Wide Introduction of Dose-Adjusted EPOCH-R In High-grade B-cell Lymphoma with MYC/BCL2 Rearrangements, DLBCL Morphology

在高MYC/BCL2易位的弥漫大B细胞淋巴瘤中,进行剂量调整的EPOCH-R方案的群体推广,该淋巴瘤具有DLBCL形态。

2025-10-170
OAAI
High-grade B-cell lymphoma, not otherwise specified: an LLMPP study.

高级别B细胞淋巴瘤,非其他特指类型:一项LLMPP研究。

2025-07-210
OAAI
Somatic IRF4 mutations and thymic tropism in primary mediastinal large B-cell lymphoma

体细胞IRF4突变和胸腺趋向性在原发性纵隔大B细胞淋巴瘤中的作用

Blood
IF23.1
2025-06-240
OA
The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative

Terry Fox Research Institute马拉松希望癌症中心网络:一项全加拿大的精准肿瘤学倡议

2025-04-010
PRE
The Phenotypic Landscape of Anaplastic Large Cell Lymphoma Supports a New Molecular Classification: An LLMPP Study

间变性大细胞淋巴瘤的表型景观支持新的分子分类: 一项LLMPP研究

2025-03-010
PRE
Drug survival of dupilumab, tralokinumab and upadacitinib in patients with atopic dermatitis: An international, real-world comparative study

度普利尤单抗、特拉斯库单抗和乌帕替尼在特应性皮炎患者中的药物生存率:一项国际性、真实世界比较研究

2025-02-063
OA
Biological and Prognostic Subgroups of Plasmablastic Lymphoma Defined By EBV Status and MYC Rearrangement- an LLMPP Study

根据EBV状态和MYC重排定义的浆细胞样淋巴瘤的生物与预后亚组——一项LLMPP研究

BLOOD
IF23.1
2024-11-050
PRE
Machine Learning Classification of Spatial Patterns of Malignant Cells Reveals Implications in Prognosis and Tumor Microenvironment Composition in Lymphoma

机器学习对恶性细胞空间模式的分类揭示了其在淋巴瘤预后和肿瘤微环境组成方面的意义

BLOOD
IF23.1
2024-11-050
PRE
A Novel Genetics-Based Classification of Advanced Follicular Lymphoma Identifies Prognostic Subgroups Following Bendamustine-Rituximab Immunochemotherapy

一种基于遗传学的晚期滤泡性淋巴瘤新型分类法,可识别接受 bendamustine-rituximab 免疫化疗后的预后亚组

BLOOD
IF23.1
2024-11-050
PRE
CSF2RB Mutations Result in Cytokine-Dependent Gain-of-Function Phenotypes in Classic Hodgkin Lymphoma

CSF2RB基因突变导致经典霍奇金淋巴瘤中细胞因子依赖性的获得性功能表型。

BLOOD
IF23.1
2024-11-050
PRE
Intra-tumoral and peripheral blood TIGIT and PD-1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma
2024-08-170
OAAI
Single Cell Resolution Spatial Modeling Uncovers Survival-associated Phenotypes in Diffuse Large B Cell Lymphoma
2024-04-150
PRE
Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment
2024-04-033
OAAI